CannaPharmaRx delays quarterly 10-Q filing for period ended June 30, 2026

• CannaPharmaRx filed a late notice for its Form 10-Q for the quarter ended June 30, 2026.
• Delay tied to obtaining and compiling required information; filing expected within five calendar days of the due date.
• Revenue totaled $276,218 for the quarter, up from $231,608 a year earlier.
• Gross loss narrowed to $138,446 from $621,210 in the prior-year quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CannaPharmaRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-006523), on August 17, 2026, and is solely responsible for the information contained therein.